We are engaged in the business of developing for market innovative products for the detection and characterization of male urological prostate disease. Our initial product is a prostate mechanical imaging system designed to aid the physician in visualizing and documenting tissue abnormalities in the prostate that have been previously detected by a digital rectal exam (“DRE”). As an adjunct to DRE, the prostate mechanical imaging system will be used following an abnormal DRE to generate a real time image and map of the prostate and to store this information electronically. Our business plan is built on the premise that the map and physical record created by the prostate mechanical imaging system will become a valuable tool in assisting physicians and patients in understanding the scope of the abnormalities that are identified with a DRE.
We recently closed on a public equity offering, announced progress on clinical trials, and exhibited our prostate mechanical imaging system at the annual American Urology association scientific meeting. Click here to view press releases.
|
